BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2003
View Archived Issues
Evidence of antiinflammatory effects for efalizumab in atopic asthma
Read More
Potential cognitive benefits suggested for donepezil and vitamin E in AD
Read More
Early response to antivirals predicts sustained response in chronic hepatitis C
Read More
Phase II laquinimod study for MS meets primary endpoint according to first analysis
Read More
Clofarabine enters pivotal European trial for ALL
Read More
Cerezyme approved for type 3 Gaucher's disease in E.U.
Read More
Genzyme completes acquisition of SangStat
Read More
Phase II program of ISIS-113715 follows encouraging phase I data
Read More
FDA approves expanded Synagis labeling for children with congenital heart disease
Read More
Medtronic acquires remaining rights to rhBMP-2
Read More
Roche and ParAllele form type 2 diabetes genetic collaboration
Read More
SBIR grant supports development of melanoma peptide vaccine
Read More
Genmab delivers antibody targeting IL-15 receptor to Amgen
Read More
Thymitaq studied in new phase I/II trial in combination with Taxotere
Read More
Lilly licenses Antares drug delivery technology
Read More
First dose level completed in phase Ib DVT trial of ThromboView
Read More
Acceptable safety profile described for NBI-3001 in recurrent malignant glioma
Read More
AstraZeneca claims novel KDR inhibitors for cancer and other disorders
Read More
Two series of piperidine-based antibacterial agents prepared and tested at GSK
Read More
New tripeptides with HCV NS3-inhibitory activity covered by Boehringer Ingelheim patent
Read More
Novo Nordisk and Boehringer Ingelheim present new histamine H3 modulators
Read More
Novel antitumor protein kinase inhibitors in early development at Vertex
Read More
Canadian scientists design new photosensitizers for cancer, ocular disorders, etc.
Read More
HARP antibiotics: a novel class for resistant Gram-positive infections
Read More
Potent and selective CCR5 antagonist for HIV highlighted by Pfizer at ICAAC
Read More
Orally bioavailable meropenem prodrugs designed by Japanese group
Read More
Aminomethylcycline antibiotic profiled at ICAAC meeting
Read More